Regeneron Pharmaceuticals, Inc. (REGN) Posts Q3 adj.-EPS of $2.40
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q3 EPS of $2.40 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)